The differential diagnosis initially considered thrombotic thrombocytopenic purpura (TTP) and other TMAs, but these were excluded based on preserved ADAMTS-13 activity (76%) and the absence of secondary triggers such as infection, autoimmune disease, or monoclonal gammopathy. The gene discussed is ADAMTS13; the disease is monoclonal gammopathy.